Top news of the week: 21.06.2022.
06:34am EDT
John Leonard built Intellia Therapeutics with Jennifer Doudna, the Nobel Prize-winning scientist who pioneered gene editing technology. Intellia has figured out how to alter disease-causing ...
With biotech in retreat, Third Rock raises $1B for life sciences investing
The fund, Third Rock’s sixth, comes amid a significant downturn in the biotech stock market, which has raised questions about the viability of young drug startups.
Third Rock raises $1.1 billion for its largest fund yet
The Boston venture capital firm plans to use the money to launch more biotechs, despite the sector’s recent downturn.
Third Rock Ventures plots next chapter after raising $1.1 billion fund
Third Rock Venture partners Abbie Celniker and Reid Huber spoke with STAT about their plans for investing their sixth and largest fund. The lion's share of the $1.1 billion they raised will ...
BioLabs Announces New Laboratory Location at Longfellow’s BioVista
BioLabs announces new laboratory location at Longfellow’s BioVista San Diego, CA (June 15, 2022) – BioInnovation Labs, “BioLabs”, the leading developer and operator of life …
Thermo’s New Single-Use Site in Utah
Thermo built its new Ogden, UT-based facility to manufacture bioprocess container systems that can be customized. These systems can be used in many manufacturing steps, such as processing, ...
Pharma Critic Wrongly Minimizes Industry’s Covid-19 Vaccine Efforts
Pfizer, which has produced the majority of Covid-19 vaccines with roughly seven billion doses to date, took no money from Operation Warp Speed (OWS) to discover, produce or distribute its ...
The Days of Big Pharma Are Over. What the Era of Big Biotech Means for Investors.
When GSK spins off its consumer health division in July, it will become one of the last drug conglomerates to shed its sideline businesses to focus on...